These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37213003)

  • 1. Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
    Muñoz AE; Pollarsky F; Marino M; Cartier M; Míguez C; Rodger EG; Vázquez H; Salgado P; Álvarez D; Romero G
    Dig Dis Sci; 2023 Aug; 68(8):3442-3450. PubMed ID: 37213003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Muñoz AE; Pollarsky F; Marino M; Cartier M; Míguez C; Vázquez H; Álvarez D; Salgado P; Romero G
    Dig Dis Sci; 2021 Sep; 66(9):3199-3208. PubMed ID: 33033975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Pose E; Napoleone L; Amin A; Campion D; Jimenez C; Piano S; Roux O; Uschner FE; de Wit K; Zaccherini G; Alessandria C; Angeli P; Bernardi M; Beuers U; Caraceni P; Durand F; Mookerjee RP; Trebicka J; Vargas V; Andrade RJ; Carol M; Pich J; Ferrero J; Domenech G; Llopis M; Torres F; Kamath PS; Abraldes JG; Solà E; Ginès P
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):31-41. PubMed ID: 31607677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Abraldes JG; Villanueva C; Aracil C; Turnes J; Hernandez-Guerra M; Genesca J; Rodriguez M; Castellote J; García-Pagán JC; Torres F; Calleja JL; Albillos A; Bosch J;
    Gastroenterology; 2016 May; 150(5):1160-1170.e3. PubMed ID: 26774179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with compensated and decompensated liver cirrhosis.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Dec; 70():54-59. PubMed ID: 31530418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Profile of Filipino Patients With Liver Cirrhosis: A 10-Year Study.
    Yap EML; Supe MGS; Yu II
    Cardiol Res; 2018 Dec; 9(6):358-363. PubMed ID: 30627286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
    Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
    J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
    Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
    Oyama K; Giugliano RP; Blazing MA; Park JG; Tershakovec AM; Sabatine MS; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2021 Oct; 78(15):1499-1507. PubMed ID: 34620406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
    Muñoz AE; Pollarsky FD; Marino M; Cartier M; Vázquez H; Salgado P; Romero G
    World J Gastroenterol; 2021 Jul; 27(28):4639-4652. PubMed ID: 34366626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis.
    Sahani S; Das D
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
    Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
    Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.
    Saxena V; Nyberg L; Pauly M; Dasgupta A; Nyberg A; Piasecki B; Winston B; Redd J; Ready J; Terrault NA
    Hepatology; 2015 Sep; 62(3):715-25. PubMed ID: 26033798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.